DOK Plus

Dosage form: tablet
Ingredients: DOCUSATE SODIUM 50mg, SENNOSIDES 8.6mg
Labeler: Cardinal Health
NDC Code: 55154-0733

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

DOK PLUS TABLETS (Docusate Sodium & Senna) 50/8.6 mg.

Drug Facts

Active ingredients
(in each tablet)
Purposes

  Docusate sodium 50 mg

  Stool softener

  Sennosides 8.6 mg

  Stimulant laxative

Purposes

  Docusate sodium 50 mg

  Stool softener

  Sennosides 8.6 mg

  Stimulant laxative

Uses
relieves occasional constipation (irregularity)
This product generally produces bowel movement in 6 to 12 hours.

Warnings

Ask a doctor before use if you have

stomach pain
nausea
vomiting
a sudden change in bowel habits that lasts over a period of 2 weeks

Ask a doctor or pharmacist before use

if you are presently taking mineral oil

Stop use and ask a doctor if

you need to use a laxative for more than 1 week
you have no bowel movement or have rectal bleeding. 

These could be signs of a serious condition

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overodse, get medical help or contact a Poison Control Center right away.

Directions
take only by mouth.  Doses may be taken as a single daily dose, preferably in the evening, or in divided doses.
agedosage

  adults and children 12 years and older

  take 2-4 tablets daily

  children 6 to under 12 years

  take 1-2 tablets daily

  children 2 to under 6 years

  take up to 1 tablet daily

  children under 2 years

  do not use

Other information
each tablet contains: sodium 6 mg/tablet VERY LOW SODIUM
each tablet contains:  calcium 20 mg/tablet

Store at 20° - 25ºC (68º - 77ºF); excursions permitted to 15º - 30ºC (59° to 86°F).  [See USP Controlled Room Temperature]

Inactive ingredients

carnauba wax, colloidal silicon dioxide, croscarmellose sodium, dibasic calcium phosphate dihydrate, FD&C red #40 aluminum lake, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, sodium benzoate, stearic acid, tapioca starch*, tartaric acid* and titanium dioxide.  *may contain these ingredients

Questions?

To Report Serious Adverse Effects Call (800) 616-2471

PN:1042

Distributed by:

MAJOR® PHARMACEUTICALS

31778 Enterprise Drive • Livonia, MI 48150  USA       

Rev. 04/12

M-14     Reorder No. 301555

Repackaged by Cardinal Health

Zanesville, OH 43701

L37710941114

PRINCIPAL DISPLAY PANEL

DOK PLUS TABLETS 50/8.6 mg.

Docusate Sodium & Senna

10 Tablets

DOK PLUS 
dok plus tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:55154-0733(NDC:0904-5643)
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
DOCUSATE SODIUM (DOCUSATE) DOCUSATE SODIUM50 mg
SENNOSIDES (SENNOSIDES) SENNOSIDES8.6 mg
Inactive Ingredients
Ingredient NameStrength
CARNAUBA WAX 
SILICON DIOXIDE 
CROSCARMELLOSE SODIUM 
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS 
FD&C RED NO. 40 
HYPROMELLOSES 
MAGNESIUM STEARATE 
CELLULOSE, MICROCRYSTALLINE 
POLYETHYLENE GLYCOL 400 
SODIUM BENZOATE 
STEARIC ACID 
TITANIUM DIOXIDE 
Product Characteristics
ColorREDScoreno score
ShapeROUNDSize10mm
FlavorImprint CodeL60;TCL
Contains    
Packaging
#Item CodePackage Description
1NDC:55154-0733-010 BLISTER PACK in 1 BAG
11 TABLET in 1 BLISTER PACK
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
Unapproved drug other06/07/2011
Labeler - Cardinal Health (188557102)
Establishment
NameAddressID/FEIOperations
Cardinal Health188557102REPACK(55154-0733)

Revised: 11/2014
 
Cardinal Health

See also...

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide
(web2)